The KK/Ta strain serves as a suitable polygenic mouse model for the common form of type 2 diabetes associated with obesity in humans. Recently, we reported the susceptibility loci contributing to type 2 diabetes and related phenotypes in KK/Ta mice. In this study, we focused on expression in the kidneys and liver of KK/Ta and BALB/c mice using differential display (DD) PCR. Zn-␣ 2 glycoprotein-1 (Azgp1) mRNA levels were increased in the kidneys and liver in KK/Ta mice, and sequence analysis revealed a missense mutation. We analyzed the relationship between this polymorphism and various phenotypes in 208 KK/Ta ؋ (BALB/c ؋ KK/Ta) F1 backcross mice. Statistical analysis revealed that Azgp1 and D17Mit218 exhibit a suggestive linkage to body weight (8 weeks) (logarithm of odds 2.3 and 2.9, respectively). Moderate gene-gene interactions were observed at these loci. Adiponectin mRNA levels in 3T3-L1 cells transfected with the expression pcDNA 3.1 vector containing Azgp1 coding sequence of KK/Ta mice were significantly higher than those of BALB/c mice. These results suggest that Azgp1 is a possible candidate gene for regulation of body weight, elucidation of polygenic inheritance, and age-dependent changes in the genetic control of obesity. Diabetes 52:2175-2181, 2003
T ype 2 diabetes and obesity are generally considered to be multifactorial and polygenic diseases associated with an increased risk of mortality and morbidity (1) . Obesity is commonly associated with insulin resistance and hyperinsulinemia and is a major risk factor for the development of type 2 diabetes (2). Adipose tissue is known to express and secrete a variety of adipocytokines that have been implicated in the development of insulin resistance. Recently, a novel adipose-specific protein, adiponectin, was discovered (3) (4) (5) (6) . In humans, plasma adiponectin concentration negatively correlates with BMI, fasting insulin concentration, and serum triglyceride (7, 8) . Weight reduction achieved by a low-calorie diet also increases plasma adiponectin concentration in both nondiabetic and diabetic patients (9) .
In mammalian tissues, mRNA expression is altered in various developmental and pathophysiological states, including type 2 diabetes. Isolation of these genes may play an important role in clarifying the pathogenesis of type 2 diabetes and related disorders. Recently, we reported (10) a genome-wide linkage analysis of KK/Ta alleles contributing to type 2 diabetes and related phenotypes using 93 microsatellite markers in 208 KK/Ta ϫ (BALB/c ϫ KK/Ta) F1 male backcross mice. KK/Ta mice had a clearly different genetic background in terms of body weight, blood glucose, impaired glucose tolerance (IGT), albuminuria, and serum triglyceride than BALB/c mice. It was suggested that these mice are suitable experimental models for human type 2 diabetes and related disorders, such as obesity, dyslipidemia, and nephropathy. In the present study, we used the differential display (DD) RT-PCR technique to identify genes that display transcriptional changes, particularly in the kidneys and liver during development or progression of type 2 diabetes (11, 12) . We analyzed the relationship between altered gene expression and mapping panel data.
of 165 bp, and partially digested samples from heterozygotes (KK/KB genotype) produced three bands of 29, 136, and 165 bp. Data analysis. Linkage analysis was performed using interval mapping. Genomic interval mapping was conducted using the Map Manager QT package program originally described by Manly (15) . To estimate positions of quantitative trait loci (QTLs), the likelihood ratio statistics were determined using the Map Manager QT package program. Logarithm of odds (LOD) scores Ն1.9 and Ն3.3 were used as thresholds for statistically suggestive and significant linkage, respectively, according to Lander and Kruglyak (16) . In addition to the criteria using the fixed levels of LOD, the permutation test was also performed in 1-cM steps for 500 permutations using the Map Manager QT package program to further estimate significance levels for QTL analysis.
Phenotyping data were analyzed by Mann-Whitney's U test or ANOVA with StatView 5.0 on a Macintosh. P Ͻ 0.05 was considered as statistically significant. Cell culture and transfection of cells with Azgp1 coding sequence. 3T3-L1 cells (American Type Culture Collection, Rockville, MD) were seeded at 1.0 ϫ 10 5 cells per well in Dulbecco's minimal essential medium (Sigma Chemical) containing 10% FCS, 25 mmol/l glucose, 100 units/ml penicillin, and 100 g/ml streptomycin (basal medium) in a 35-mm Petri dish at 37°C in 5% CO 2 . Then, transfection was performed with FuGENE6 (Roche, Indianapolis, IN) according to the manufacturer's instructions using the expression pcDNA 3.1 vector (Invitrogen) containing the Azgp1 coding sequence of KK/Ta (KK vector) and BALB/c (BALB vector) mice or not containing the Azgp1 coding sequence (empty vector) for 48 h. Confluent preadipocytes were cultured for 2 days in basal medium further supplemented with 1 mol/l insulin (Sigma Chemical), 0.5 mmol/l isobuthylmethylxanthine (Sigma Chemical), and 0.1 mol/l dexamethasone (Sigma Chemical), followed by another 2 days in basal medium supplemented only with 1 mol/l insulin. Semiquantitative RT-PCR analysis. Total RNA was isolated from the cells using Trizol. Total RNA was reverse transcribed using oligo dT primers and reverse transcriptase. The single-strand cDNA product was denatured and amplified with two primers under the following conditions: adiponectin: forward primer 5Ј-AAG GAC AAG GCC GTT CTC T-3Ј and reverse primer 5Ј-TAT GGG TAG TTG CAG TCA GTT GG-3Ј. The cycles consisted of 28 cycles at 95°C for 15 s, 60°C for 15 s, and 72°C for 15 s. Tumor necrosis factor (TNF)-␣: forward primer 5Ј-CTC TTC AAG GGA CAA GGC TG-3Ј and reverse primer 5Ј-CGG ACT CCG CAA AGT CTA AG-3Ј. The cycles consisted of 29 cycles at 95°C for 20 s, 58°C for 20 s, and 72°C for 20 s. Azgp1: forward primer 5Ј-ATG GTG CCT GTC CTG CTG TC-3Ј and reverse primer 5Ј-TTA CTG AGG CTG AGC TAC AAC-3Ј. The cycles consisted of 24 cycles at 95°C for 40 s, 57°C for 40 s, and 72°C for 1 min 30 s. The PCR product was separated on 2.0% agarose gels and visualized by ethidium bromide staining. Gels were scanned using Master Scan (Scanalytics, Billerica, MA), and the signal intensity of bands was counted. Each experiment included amplification of GAPDH, and the intensities of each of the cDNA bands were normalized to the GAPDH band intensities, as previously reported (17) .
RESULTS
Analysis of Azgp1 mRNA expression. Using RNA from kidneys and liver of 8-and 20-week-old KK/Ta and BALB/c mice, results showed that one of the differential intensity bands was a 206-bp cDNA (differential expression 1 [DE1]) and that levels increased in both the diabetic mouse kidneys and liver (Fig. 1A) . The cloning and sequencing cDNA revealed 98% homology with the mouse Azgp1 gene. DE1 was used as a probe for Northern blot analysis. Azgp1 mRNA levels were increased in diabetic mouse kidneys (Fig. 1B) . There was no significant difference in Azgp1 mRNA levels in the liver between KK/Ta and BALB/c mice by Northern blot analysis. Increases of Azgp1 mRNA levels were similar in the heart, lungs, spleen, intestine, muscle, and adipose tissues of KK/Ta and BALB/c mice. Analysis of the Azgp1 coding sequence. Sequence analysis revealed three single nucleotide polymorphisms. One was a C3 A substitution at nucleotide 71, which predicted the replacement of serine with tyrosine at codon 24 of the Azgp1 (Ser24Tyr Azgp1) (Fig. 2) . The others were silent mutations at nucleotide 90 (ACT Thr 3 ACC Thr ) and 306 (TAT Tyr 3 TAC Tyr ).
Azgp1: A CANDIDATE GENE FOR OBESITY
Chromosomal loci for body weight and serum triglyceride levels in KK/Ta ؋ (BALB/c ؋ KK/Ta) F1 backcross mice. A comparison with body weight and serum triglyceride levels by genotype at Azgp1, D4Mit336, and D17Mit218 loci is shown in Table 1 . Loci for body weight levels (8 weeks of age) were observed with a peak LOD score of 2.3 (P ϭ 0.001) at Azgp1 locus and 2.9 (P ϭ 0.0003) at D17Mit218 (Fig. 3) . The results showed that the likelihood ratio statistic values were 10.8 and 13.0, respectively. These levels almost reached the critical value of significant linkage (11.4) at Azgp1 locus and the critical value of significant linkage (9.5) at D17Mit218 locus using the permutation test. The body weight and serum triglyceride levels in mice with KK/KK genotype (homozygous for KK/Ta alleles) at Azgp1 locus were significantly higher than those in mice with KK/KB (heterozygous for KK/Ta and BALB/c alleles) at that locus. Conversely, body weight and serum triglyceride levels in mice with KK/KB genotype at D17Mit218 locus were significantly higher than those in mice with KK/KK at that locus. Other clinical parameters, such as plasma insulin, blood glucose, total cholesterol, and urinary albumin excretion, showed no significant change between KK/KK and KK/KB genotypes at these three loci. Fig. 4A -F the progeny in group B showed significantly higher body weights and serum triglyceride levels than those in group D. Figure 4G -I shows that body weights and serum triglyceride levels in group C were significantly higher than those in group A. Analysis of adiponectin and TNF-␣ mRNA expression in 3T3-L1 cells. To determine whether Azgp1 affects obesity (body weight), 3T3-L1 cells were transfected with KK, BALB, or empty vector. Adiponectin mRNA levels in 3T3-L1 cells transfected with KK vector were significantly higher than those with BALB or empty vector. However, there was no significant difference in changes of TNF-␣ mRNA levels among the three vectors. Azgp1 mRNA levels 
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showed no change between KK and BALB vectors and were not detected in empty vector (Fig. 5) .
DISCUSSION
In the present study, a possible candidate gene for obesity was discovered using the KK/Ta mouse as a spontaneous animal model of type 2 diabetes (18 -21). Using DD RT-PCR, we identified alternative expression of Azgp1 mRNA, which was increased in KK/Ta mouse kidneys and liver. However, the Azgp1 mRNA levels in the liver of KK/Ta mice did not differ from those of BALB/c mice by Northern blot analysis. It is postulated that the Azgp1 mRNA levels in the liver might be high in Northern blot analysis or the sensitivity of Northern blot analysis is lower than that of DD RT-PCR. Since the gene expression of Azgp1 mRNA in KK/Ta mice was different from that in BALB/c mice, we conducted a sequence comparison of the coding region in KK/Ta and BALB/c mice. We identified a single nucleotide polymorphism in exon 2 of Azgp1 in KK/Ta mice. This polymorphism was a missense mutation (TCT Ser 3 TAT Tyr ) at codon 24 of Azgp1, making it likely that Azgp1 is responsible for type 2 diabetes and related phenotypes in KK/Ta mice.
Recently, Hirai et al. (22) reported that Azgp1 stimulates glycerol release from isolated mouse epididymal adipocytes in a dose-dependent manner and adenylate cyclase in mouse adipocyte plasma membrane in a GTP-dependent manner. The lipid-mobilizing factor is homologous with the plasma protein Azgp1 in the amino acid sequence, electrophoretic mobility, and immunoreactivity. Only 59% of the overall amino acid sequence of Azgp1 is identical between humans and mice (13) . However, Sanchez and colleagues (23, 24) reported that the Azgp1 sequence, in both humans and mice, shares up to 100% in specific regions such as codon 14, 73, 76, 77, 101, 115, 117, 134, 148, 154, and 161 of the human Azgp1 sequence, which is hypothesized to be important in lipid catabolism. They suggested that Azgp1 amino acid sequence at codon 24 is not important in the modulation of lipid catabolism (23, 24) . However, the sequence of Azgp1 amino acid is conserved in humans, rats, and mice. Since this amino acid was presented in the helices of the Azgp1-␣ 1 and -␣ 2 domains, this polymorphism may modulate the lipid metabolism or altered shape of Azgp1. Further studies are necessary to determine whether this polymorphism affects lipid catabolism.
As shown in Fig. 4 , longitudinal evaluation of body weight in F1 mice revealed a different type of inheritance at a young (recessive at 8 weeks of age) versus older (incomplete dominant at 20 weeks of age) age, indicating age-dependent changes in the genetic control of body weight. The present study showed that the loci for obesity were different between young (Azgp1 and D17Mit218) and old (D4Mit336) KK/Ta ϫ (BALB/c ϫ KK/Ta) F1 backcross mice.
In our previous study (10) , the development of obesity in KK/Ta ϫ (BALB/c ϫ KK/Ta) F1 backcross mice was positively correlated with hyperinsulinemia, IGT, and dyslipidemia. However, none of the three loci (D4Mit336, Azgp1, and D17Mit218) showed linkage with hyperinsulinemia or IGT in our previous mapping data. It appeared that the genetic susceptibilities of obesity and glucose tolerance are independently controlled. The evidence that genetic loci on chromosomes 4, 5, and 17 contribute to body weight is only suggestive, with LOD scores of 2.0, 2.3, and 2.9, respectively. However, interestingly, each locus is a moderate contributor to the overall susceptibility to obesity. It appears that obesity was not developed due to one gene alone. In general, human obesity, as well as type 2 diabetes, is considered to be a polygenic and multifactorial disease. In polygenic diseases, a single mutation could induce different phenotypes in different individuals, since the phenotype is likely to reflect interaction with other genes and environmental factors. These results clearly demonstrated that body weight is related to polygenic effects. In addition to the difference of Azgp1 mRNA expression between KK/Ta and BALB/c mice, several polymorphisms within Azgp1 might contribute to expression of the gene that regulates body weight or lipid concentration. However, C57BL/6, regardless of diet-induced diabetes and obesity (25) , encoded for Y at codon 24 of the Azgp1 amino acid sequence in the same way as KK/Ta mice. These results suggested that this polymorphism might modify the type 2 diabetes-related phenotype, such as obesity, rather than be responsible for type 2 diabetes. The present study did not show Azgp1 mRNA expression in adipose tissue of both KK/Ta and BALB/c mice, although Azgp1 is linked to body weight. Thus, it is hypothesized that Azgp1 affects the adipocytes by endocrine signaling or local signaling to a certain extent.
When 3T3-L1 cells were transfected with KK, BALB, or empty vector, adiponectin mRNA levels in 3T3-L1 cells transfected with KK vector were significantly higher than those transfected with BALB or empty vector. However, there was no difference in the changes of TNF-␣ mRNA levels for the three vectors. In general, the grade of obesity is associated with overexpression of TNF-␣ in adipose tissues and elevated TNF-␣ levels in the circulation (26, 27) . Recent studies demonstrated that adiponectin decreases body weight and that the levels of serum adiponectin are related to the levels of obesity (7, 9, 28) . In our hypothesis, if hyperglycemia/obesity continues, then Azgp1 mRNA levels may increase to correct this condition and also increase adiponectin mRNA levels, as shown in Fig. 6 . Since Azgp1 mRNA levels in kidney at 20 weeks of age are increased compared with those at 8 weeks of age, elevated Azgp1 mRNA expression might not be a cause but a result of hyperglycemia/obesity. These two (Azgp1 and adiponectin) genes might collaborate to decrease body weight. The missense mutation between KK/Ta and BALB/c mice might contribute in part to expression of the gene which regulates body weight. Azgp1 might affect adiponectin mRNA levels through some pathway rather than TNF-␣ signaling. Further genetic and functional studies are necessary to determine whether Azgp1 affects obesity.
Using a mouse model of obese type 2 diabetes, it appears that Azgp1 is a possible candidate gene for obesity and is involved in the polygenic inheritance and age-dependent changes in the genetic control of obesity and epistatic interactions between QTLs in the development of obesity. This complex inheritance pattern, which is associated with gene-gene interactions, may be very 
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important for understanding common forms of human type 2 diabetes or obesity.
